ALK and non-small cell lung carcinoma: The frequency of ALK translocations in NSCLC was published as 1–2% [27]; i.e., based on the above-mentioned epidemiological data of approximately 47,005 newly diagnosed NSCLC patients [28] per year, a minimum of between 470 and 940 patients per year would be eligible for ALK testing in Germany.